Treatment with abatacept, which inhibits CD28 mediated T-cell activation, also mitigated the accelerated atherosclerosis and elevated serum levels of IFN-γ seen in ApoE3-Leiden and Apoe -/-mice [72, 73]. This evidence concerns the gene APOE and atherosclerosis.